Provides aseptic carton packaging systems for beverage and liquid food products. Manufactures aseptic carton packaging filling machines. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
Average growth of 12% a year over the last 4 years. Red columns mark years that ended in a loss.
At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.
This company is not turning a profit, so the market is pricing its sales instead: 1.6× for every dollar of annual revenue.
No analyst target is on record for this company.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
R&D Investment: Spending on future research is low.
The stock trades 46% below its peak. The market has trimmed its expectations for the company.
Over the last 4 years, sales grew about 12% a year on average.
A loss of $101.6M against $3.8B in annual sales. And on top of that, sales fell from the year before.
The share set aside for the future is small; the pace of new ideas may slow. Council score: 2/10.
As the slice kept from each sale thins out, so does the profit. Council score: 3/10.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the revenue breakdown.